DUBLIN, Mar 10, 2017 /PRNewswire/ — Research and Markets has announced the addition of the “Global T-Cell Immunotherapy Pipeline Analysis, 2016” report to their offering. The T-cell immunotherapy pipeline is very strong with a total of 139 drug candidates. Pharma giant such as Novartis, Kite Pharmaceuticals, Juno Therapeutics, Inc. and Sorrent Therapeutics, Inc. are actively involved…